Oculus Innovative Sciences has enrolled first patient, under an FDA-reviewed protocol, in a clinical study of its Microcyn hydrogel. Microcyn hydrogel is indicated for use in hypertrophic or keloid scars management. The double-blind, ...
Tags: Oculus Innovative Sciences, Microcyn hydrogel, keloid scars management